BRUIJN, Noor, van Lohuizen ROMY, Malgorzata BORON, Mira FITZEK, Francesca GABRIELE, Giada GIULIANI, Laura MELGAREJO, Pavel ŘEHULKA, Gabriele SEBASTIANELLI, Paul TRILLER, Simone VIGNERI, Behiye OZCAN and van den Brink Antoinette MAASSEN. Influence of metabolic state and body composition on the action of pharmacological treatment of migraine. JOURNAL OF HEADACHE AND PAIN. LONDON: BMC, 2024, vol. 25, No 1, p. 1-22. ISSN 1129-2369. Available from: https://dx.doi.org/10.1186/s10194-024-01724-3.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Influence of metabolic state and body composition on the action of pharmacological treatment of migraine
Authors BRUIJN, Noor, van Lohuizen ROMY, Malgorzata BORON, Mira FITZEK, Francesca GABRIELE, Giada GIULIANI, Laura MELGAREJO, Pavel ŘEHULKA (203 Czech Republic, belonging to the institution), Gabriele SEBASTIANELLI, Paul TRILLER, Simone VIGNERI, Behiye OZCAN and van den Brink Antoinette MAASSEN.
Edition JOURNAL OF HEADACHE AND PAIN, LONDON, BMC, 2024, 1129-2369.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30210 Clinical neurology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 7.400 in 2022
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1186/s10194-024-01724-3
UT WoS 001160025300001
Keywords in English CGRP; Metabolic disorders; Diabetes mellitus; Migraine; Obesity; Lifestyle
Tags 14110127, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 29/4/2024 14:09.
Abstract
Migraine is a disabling neurovascular disorder among people of all ages, with the highest prevalence in the fertile years, and in women. Migraine impacts the quality of life of affected individuals tremendously and, in addition, it is associated with highly prevalent metabolic diseases, such as obesity, diabetes mellitus and thyroid dysfunction. Also, the clinical response to drugs might be affected in patients with metabolic disease due to body composition and metabolic change. Therefore, the efficacy of antimigraine drugs could be altered in patients with both migraine and metabolic disease. However, knowledge of the pharmacology and the related clinical effects of antimigraine drugs in patients with metabolic disease are limited. Therefore, and given the clinical relevance, this article provides a comprehensive overview of the current research and hypotheses related to the influence of metabolic state and body composition on the action of antimigraine drugs. In addition, the influence of antimigraine drugs on metabolic functioning and, vice versa, the influence of metabolic diseases and its hormonal modulating medication on migraine activity is outlined. Future exploration on personalizing migraine treatment to individual characteristics is necessary to enhance therapeutic strategies, especially given its increasing significance in recent decades.
Links
LM2023049, research and development projectName: Český národní uzel Evropské sítě infrastruktur klinického výzkumu
Investor: Ministry of Education, Youth and Sports of the CR
PrintDisplayed: 20/7/2024 12:24